DocGo Inc. (DCGO) Form 8-K — Nov 9, 2026
DocGo (Nasdaq: DCGO) reported Q3 2026 revenue of $73.4 million, up from $70.8 million a year ago, with GAAP gross margin jumping to 29.7% from 20.0% and adjusted EBITDA loss narrowing to ($3.2) million from ($7.2) million. Net loss improved to ($18.3) million from ($29.7) million. The Board has initiated a CEO search as Lee Bienstock's employment contract expires December 31, 2026; he will remain CEO through the transition and at least March 31, 2027. Heidrick & Struggles is leading the search.
Key figures
- Revenue
- 73431205
- Guidance
- Full-year 2026 revenue approximately $300 million (down from prior $305-310 million); full-year 2026 adjusted EBITDA of ($17-22) million, unchanged
- Revenue Yoy
- 3.7% increase vs. $70.8M in Q3 2025
- Total Assets
- 173900854
- Cash Position
- 19107209
- Shares Outstanding
- 98992347
- Nine month revenue
- $222.4M vs $247.3M prior year
- Mobile health revenue
- $20.2M
- Adjusted ebitda q3 2025
- -$7.2M
- Adjusted ebitda q3 2026
- -$3.2M
- Gaap gross margin q3 2026
- 29.7% vs 20.0% in Q3 2025
- Adjusted gross margin q3 2026
- 33.3%
- Gross margin improvement vs q2
- 280 basis points
- Medical transportation revenue
- $53.3M
- Transportation gross margin ex upstate ny
- 36.7%
AI analysis
Red flags6 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.